Clin Case Rep Int | Volume 6, Issue 1 | Case Study | Open Access

Lack of Efficacy of Daratumumab in a Patient with Severe Refractory Rheumatoid Arthritis

Iñigo González Mazón1, Enrique M Ocio2,3, Mario Agudo Bilbao4, Marcos López-Hoyos3,5 and Víctor M Martínez-Taboada1,3*

1 Department of Rheumatology, Marqués de Valdecilla University Hospital, Spain
2Department of Hematology, Marqués de Valdecilla University Hospital, Spain
3University of Cantabria, Spain
4Department of Rheumatology, Hospital Sierrallana, Spain
5Department of Immunology, Marqués de Valdecilla University Hospital, Spain

*Correspondance to: Víctor M Martínez-Taboada 

Fulltext PDF

Abstract

#

Keywords:

Rheumatoid arthritis; Refractory; Daratumumab

Citation:

Mazón IG, Ocio EM, Bilbao MA, López- Hoyos M, Martínez-Taboada VM. Lack of Efficacy of Daratumumab in a Patient with Severe Refractory Rheumatoid Arthritis. Clin Case Rep Int. 2022; 6: 1374.

Subscribe to Our Newsletter